NCT04255147View on ClinicalTrials.gov

Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

November 6, 2023

Study Completion Date

November 6, 2033

Conditions
Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL

Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells

Cryopreserved allogeneic umbilical cord tissue-derived mesenchymal stromal cells are thawed and administered intravenously.

Trial Locations (2)

K1T 8L6

The Ottawa Hospital - General Campus, Gloucester

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Ontario Institute of Regenerative Medicine (OIRM)

UNKNOWN

collaborator

Stem Cell Network

OTHER

lead

Ottawa Hospital Research Institute

OTHER